. Author manuscript; available in PMC: 2021 Jun 17.

Published in final edited form as: Ann Allergy Asthma Immunol. 2011 Jun 29;107(2):171–178. doi: 10.1016/j.anai.2011.05.016

Table 5.

Mean Change from Baseline to End of Study (Standard Error) of Olfactory Thresholds for ICX72 and Placebo Groups

	ICX72 (N = 14)		Placebo (N = 17)
	Baseline	Change: baseline–end	Baseline	Change: baseline–end

Olfactory Threshold	6.7 (0.4)	−1.0 (0.6)	6.1 (0.6)	+0.1 (0.5)

Abbreviation: N, number of patients.

A negative change (higher value at end of study) indicates improved olfaction.

Baseline (defined as data collected during visit 2 predrug) differences between groups were not significantly different (P > .05). Mean changes from baseline to end of study were not significantly different between ICX72 and placebo groups (P > .05). End of study means were significantly different between ICX72 (7.7) and placebo (6.0) (P < .05).